JP2008512117A5 - - Google Patents

Download PDF

Info

Publication number
JP2008512117A5
JP2008512117A5 JP2007531167A JP2007531167A JP2008512117A5 JP 2008512117 A5 JP2008512117 A5 JP 2008512117A5 JP 2007531167 A JP2007531167 A JP 2007531167A JP 2007531167 A JP2007531167 A JP 2007531167A JP 2008512117 A5 JP2008512117 A5 JP 2008512117A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
domain
protein
fusion protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007531167A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008512117A (ja
JP4764881B2 (ja
Filing date
Publication date
Priority claimed from US10/939,262 external-priority patent/US7807174B2/en
Application filed filed Critical
Publication of JP2008512117A publication Critical patent/JP2008512117A/ja
Publication of JP2008512117A5 publication Critical patent/JP2008512117A5/ja
Application granted granted Critical
Publication of JP4764881B2 publication Critical patent/JP4764881B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007531167A 2004-09-10 2005-07-21 新規の治療タンパク質ベースの分子クラス Expired - Fee Related JP4764881B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/939,262 US7807174B2 (en) 2002-11-22 2004-09-10 Class of therapeutic protein based molecules
US10/939,262 2004-09-10
PCT/US2005/025831 WO2006031291A2 (en) 2004-09-10 2005-07-21 A novel class of therapeutic protein based molecules

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010153231A Division JP5307082B2 (ja) 2004-09-10 2010-07-05 新規の治療タンパク質ベースの分子クラス

Publications (3)

Publication Number Publication Date
JP2008512117A JP2008512117A (ja) 2008-04-24
JP2008512117A5 true JP2008512117A5 (enExample) 2009-12-17
JP4764881B2 JP4764881B2 (ja) 2011-09-07

Family

ID=36060467

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007531167A Expired - Fee Related JP4764881B2 (ja) 2004-09-10 2005-07-21 新規の治療タンパク質ベースの分子クラス
JP2010153231A Expired - Fee Related JP5307082B2 (ja) 2004-09-10 2010-07-05 新規の治療タンパク質ベースの分子クラス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010153231A Expired - Fee Related JP5307082B2 (ja) 2004-09-10 2010-07-05 新規の治療タンパク質ベースの分子クラス

Country Status (16)

Country Link
US (2) US7807174B2 (enExample)
EP (4) EP3530734A1 (enExample)
JP (2) JP4764881B2 (enExample)
KR (1) KR20070064619A (enExample)
CN (2) CN101426906B (enExample)
AU (1) AU2005285461B2 (enExample)
BR (1) BRPI0515646B8 (enExample)
CA (2) CA2823429C (enExample)
DK (3) DK3018204T3 (enExample)
ES (3) ES2554787T3 (enExample)
IL (3) IL181779A (enExample)
PT (3) PT3018204T (enExample)
RU (1) RU2468080C2 (enExample)
TR (1) TR201905393T4 (enExample)
WO (1) WO2006031291A2 (enExample)
ZA (1) ZA200702915B (enExample)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100210528A1 (en) * 1999-03-05 2010-08-19 Leland Shapiro Compositions, methods and uses for inhibition and/or treatment of influenza infection
AU2003294401C1 (en) * 2002-11-22 2008-09-18 Ansun Biopharma, Inc. Broad spectrum anti-viral therapeutics and prophylaxis
US8512710B2 (en) 2002-11-22 2013-08-20 Ansun Biopharma, Inc. Class of therapeutic protein based molecules
US7807174B2 (en) * 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
TWI395668B (zh) * 2004-11-10 2013-05-11 日立化成工業股份有限公司 A metal foil with an adhesion aid and a printed circuit board using the same
KR20080083266A (ko) * 2005-10-25 2008-09-17 엠엔디 다이어그노스틱 리미티드 인플루엔자 바이러스의 검출용 조성물 및 이를 이용한 키트및 방법
KR20150001844A (ko) 2006-01-24 2015-01-06 넥스바이오, 인코퍼레이티드 고분자 미소 구체들의 조제를 위한 기술
AU2015215955B2 (en) * 2006-01-24 2016-12-01 Ansun Biopharma, Inc. Technology for preparation of macromolecular microspheres
AU2013237761B8 (en) * 2006-01-24 2015-06-04 Ansun Biopharma, Inc. Technology for preparation of macromolecular microspheres
US8273381B1 (en) * 2006-04-14 2012-09-25 Auburn University Compositions for and methods of controlling olfactory responses to odorants
US20100143972A1 (en) * 2006-12-14 2010-06-10 Horswill Alexander R Method of Making Cyclic Polypeptides with Inteins
US8012733B2 (en) * 2007-02-20 2011-09-06 Dsm Ip Assets B.V. Sialidases
ES2550755T3 (es) * 2007-08-03 2015-11-12 Romark Laboratories, L.C. Compuestos de tiazolida sustituidos con alquilsulfonilo
CN105853415A (zh) 2009-05-12 2016-08-17 罗马克实验室有限公司 卤代烷基杂芳基苯甲酰胺化合物
MX391013B (es) 2009-06-26 2025-03-21 Romark Laboratories Lc Compuestos y metodos para tratar influenza.
BR112012002163A2 (pt) * 2009-07-31 2015-11-03 Danisco Us Inc proteases com regiões pré-pró modificadas
CA2780193A1 (en) * 2009-11-06 2011-05-12 Nexbio, Inc. Methods, compounds and compositions for treatment and prophylaxis in the respiratory tract
AU2013221230A1 (en) * 2012-02-17 2014-10-02 Ansun Biopharma, Inc. Methods, compounds and compositions for treatment of parainfluenza virus in immunocompromised patients
WO2014005107A2 (en) * 2012-06-28 2014-01-03 Ansun Biopharma, Inc. Microparticle formulations for delivery to the upper and central respiratory tract and methods of manufacture
EP2866792A4 (en) 2012-06-28 2016-08-17 Ansun Biopharma Inc MICROPARTICLE FORMULATIONS FOR DELIVERY TO LOWER AND CENTRAL RESPIRATORY PATHS AND METHOD OF PREPARING THEM
MX380585B (es) 2012-12-24 2025-03-12 Coagulant Therapeutics Corp Polipeptidos del factor vii de acción corta.
PT3524617T (pt) 2013-03-15 2023-07-12 Gladiator Biosciences Inc Domínios gla como agentes terapêuticos
WO2014152524A2 (en) * 2013-03-15 2014-09-25 Ansun Biopharma, Inc. Novel method of protein purification
US20160101161A1 (en) * 2013-06-03 2016-04-14 Ansun Biopharma, Inc. Anti-viral therapeutic for infection of the eye
US10300116B2 (en) 2013-06-10 2019-05-28 Ansun Biopharma, Inc. Treatment for BK polyomavirus infection
US20160120961A1 (en) * 2013-06-10 2016-05-05 Ansun Biopharma, Inc. Treatment of merkel cell polyomavirus infection
WO2015184356A1 (en) 2014-05-30 2015-12-03 Ansun Biopharma, Inc. Treatment of middle east respiratory syndrome coronavirus
US10328128B2 (en) * 2014-09-17 2019-06-25 Ansun Biopharma, Inc. Treatment of infection by human enterovirus D68
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
WO2016115616A1 (en) * 2015-01-21 2016-07-28 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health Inhibition of cellular proteases as treatment for influenza
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
WO2017015491A1 (en) * 2015-07-21 2017-01-26 Thomas Jefferson University Gene therapies for neurodegenerative disorders targeting ganglioside biosynthetic pathways
EP3458085B1 (en) 2016-05-20 2022-12-07 Octapharma AG Glycosylated vwf fusion proteins with improved pharmacokinetics
JP7187024B2 (ja) 2016-07-01 2022-12-12 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 標的化された細胞表面編集のための複合体
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
KR102608876B1 (ko) 2017-05-26 2023-11-30 게노비스 에이비 글리칸 분석을 위한 효소
PE20201462A1 (es) 2017-09-05 2020-12-17 Gladiator Biosciences Inc Metodo de direccionamiento de exosomas
US11965188B2 (en) 2018-01-03 2024-04-23 Palleon Pharmaceuticals Inc. Recombinant human sialidases, sialidase fusion proteins, and methods of using the same
GB201800274D0 (en) * 2018-01-08 2018-02-21 Enzymatica Ab Novel treatments
GB201803197D0 (en) 2018-02-27 2018-04-11 Pneumagen Ltd Viral treatment
JP2021531042A (ja) * 2018-07-20 2021-11-18 アンサン バイオファーマ, インク.Ansun Biopharma, Inc. 癌細胞、免疫細胞及び腫瘍微小環境へのシアリダーゼの送達
CN109991649B (zh) * 2019-03-26 2021-04-06 华中科技大学 一种制备无机闪烁体膜的方法
JP7343890B2 (ja) * 2019-04-26 2023-09-13 国立大学法人東海国立大学機構 シアリダーゼ活性を有する酵素剤及びその利用
CN110038122A (zh) * 2019-05-23 2019-07-23 武汉真福医药股份有限公司 枯草杆菌纤溶酶在治疗支气管炎药物中的应用
CN114340637A (zh) 2019-07-03 2022-04-12 阿伊里斯株式会社 用于治疗流感病毒感染症的药物组合物
CN111450236B (zh) * 2020-02-25 2023-04-07 西北大学 一种用于阻断冠状病毒感染的制剂
WO2021217053A1 (en) * 2020-04-24 2021-10-28 Rezolute, Inc. Plasma kallikrein inhibitors for the treatment of ards and related conditions
WO2021252129A1 (en) * 2020-06-10 2021-12-16 The Penn State Research Foundation Process and system to lessen human coronavirus transmission and spread
WO2022147480A1 (en) 2020-12-30 2022-07-07 Ansun Biopharma, Inc. Oncolytic virus encoding sialidase and multispecific immune cell engager
CA3220244A1 (en) * 2021-06-09 2022-12-15 Jeffrey WAGNER Engineered microorganisms for detection of diseased cells

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3439089A (en) * 1968-03-27 1969-04-15 Merck & Co Inc Medicated hard candy
EP0286239B1 (en) * 1987-03-10 1996-03-13 New England Biolabs, Inc. Production and purification of a protein fused to a binding protein
US5643758A (en) * 1987-03-10 1997-07-01 New England Biolabs, Inc. Production and purification of a protein fused to a binding protein
RU2054180C1 (ru) 1991-08-21 1996-02-10 Жирнов Олег Петрович (н/п) Способ лечения вирусных респираторных инфекций
US5376633A (en) * 1992-09-30 1994-12-27 Lezdey; John Method for deactivating viruses in blood component containers
US5985859A (en) 1994-04-14 1999-11-16 The University Of Alabama Methods of inhibiting bacterial sialidase
DE69527924T2 (de) * 1994-06-14 2003-01-09 Genencor International, Inc. Hitzebeständige xylanasen
CN100409844C (zh) * 1995-02-27 2008-08-13 吉里德科学公司 神经氨酸苷酶抑制剂
GB9513683D0 (en) * 1995-07-05 1995-09-06 Ciba Geigy Ag Products
WO1998031817A2 (en) 1997-01-14 1998-07-23 Hopital Sainte-Justine Human lysosomal sialidase and therapeutic uses thereof
US6251392B1 (en) * 1997-10-20 2001-06-26 Epicyte Pharmaceuticals, Inc. Epithelial cell targeting agent
US6737511B1 (en) * 1999-08-16 2004-05-18 The United States Of America As Represented By The Department Of Health And Human Services Receptor-mediated uptake of an extracellular BCL-xL fusion protein inhibits apoptosis
US20020025320A1 (en) * 1999-08-20 2002-02-28 Prosper Boyaka Sialidases as mucosal adjuvants
CN1405562A (zh) * 2002-10-24 2003-03-26 肖洪武 一种唾液酸酶测定试剂
AU2003294401C1 (en) * 2002-11-22 2008-09-18 Ansun Biopharma, Inc. Broad spectrum anti-viral therapeutics and prophylaxis
US7807174B2 (en) * 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
DE10258400A1 (de) * 2002-12-13 2004-06-24 N.V. Nutricia Trans-Sialidasen aus Trypanosoma congolense
KR20150001844A (ko) * 2006-01-24 2015-01-06 넥스바이오, 인코퍼레이티드 고분자 미소 구체들의 조제를 위한 기술

Similar Documents

Publication Publication Date Title
JP2008512117A5 (enExample)
RU2007112502A (ru) Новый класс терапевтических белковых молекул
JP2006508193A5 (enExample)
AU2008259768B2 (en) Compositions for delivering medicaments into the lungs, uses thereof
JP2010524849A5 (enExample)
CN116033926A (zh) 针对ace2靶向病毒可用的结合蛋白
AU2015202864A1 (en) Fibronectin type III domain based scaffold compositions, methods and uses
CN113264990B (zh) 抑制新型冠状病毒(sars-cov-2)的多肽和其应用
JP2023029957A5 (enExample)
JP2005512522A (ja) Ｉｌ−１３ムテインタンパク質、抗体、組成物、方法および使用
JP2014506450A5 (enExample)
JP2017529326A5 (enExample)
WO2024239980A1 (zh) 重组表达蛋白在预防/或治疗呼吸道疾病中的应用
AU2010306840A1 (en) Recombinant human CC10 protein for treatment of influenza
JP7009625B2 (ja) Ｈ３ｎ２亜型インフルエンザウイルスのヘマグルチニンタンパク質の突然変異体及びその使用
CN117050166B (zh) 中和呼吸道合胞病毒的c-型单域抗体及应用
TW202317600A (zh) 預防多種病毒感染的多價疫苗
EP3638282A1 (en) Hydrochloride salts of c5a receptor agonist peptides
CN116782920A (zh) 用于治疗病毒感染的神经毡蛋白和血管紧张素转化酶2融合肽
HUE029250T2 (en) For use in the treatment of interferon-beta, influenza-induced lower respiratory diseases
WO2016200916A1 (en) Treatment of human metapneumovirus
CN105542003B (zh) 一种针对rsv粘附g蛋白表面抗原的全人源单克隆抗体
CN117209612A (zh) 融合蛋白及其应用
CN117186239A (zh) 融合蛋白及其应用
CN107365784A (zh) 一种用于递送至中枢神经系统的融合蛋白及合成方法